PHILADELPHIA– A subcutaneous injection of the immune-boosting drug teclistamab was figured out to be stable and elicit responses in a majority of patients with relapsed…
PHILADELPHIA– A subcutaneous injection of the immune-boosting drug teclistamab was figured out to be stable and elicit responses in a majority of patients with relapsed…